Selurampanel

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSelurampanel
Drug Alias Nameselurampanel司芦帕奈selurampanelum塞鲁帕奈BGG-492 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsSeizuresMigraine DisordersEpilepsy, Reflex +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[20] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsSeizuresMigraine DisordersEpilepsy, Reflex +[7] 

Other Information

ATC CodeN/A
Related LinksWikipedia